Çek Cumhuriyeti -
Çekçe -
SUKL (Státní ústav pro kontrolu léčiv)
memantin sandoz 20mg potahovaná tableta
sandoz s.r.o., praha array - 11425 memantin-hydrochlorid - potahovaná tableta - 20mg - memantin
Çek Cumhuriyeti -
Çekçe -
SUKL (Státní ústav pro kontrolu léčiv)
memixa 10mg potahovaná tableta
ardez pharma, spol. s r.o., kosoř array - 11425 memantin-hydrochlorid - potahovaná tableta - 10mg - memantin
Çek Cumhuriyeti -
Çekçe -
SUKL (Státní ústav pro kontrolu léčiv)
memixa 20mg potahovaná tableta
ardez pharma, spol. s r.o., kosoř array - 11425 memantin-hydrochlorid - potahovaná tableta - 20mg - memantin
Çek Cumhuriyeti -
Çekçe -
SUKL (Státní ústav pro kontrolu léčiv)
memolan 10mg potahovaná tableta
g.l. pharma gmbh, lannach array - 11425 memantin-hydrochlorid - potahovaná tableta - 10mg - memantin
Çek Cumhuriyeti -
Çekçe -
SUKL (Státní ústav pro kontrolu léčiv)
memolan 20mg potahovaná tableta
g.l. pharma gmbh, lannach array - 11425 memantin-hydrochlorid - potahovaná tableta - 20mg - memantin
Çek Cumhuriyeti -
Çekçe -
SUKL (Státní ústav pro kontrolu léčiv)
memigmin 10mg potahovaná tableta
egis pharmaceuticals plc, budapešť array - 11425 memantin-hydrochlorid - potahovaná tableta - 10mg - memantin
Avrupa Birliği -
Çekçe -
EMA (European Medicines Agency)
dimethyl fumarate mylan
mylan ireland limited - dimethyl fumarát - roztroušená skleróza, relaps-remitentní - imunosupresiva - dimethyl fumarate mylan is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.
Avrupa Birliği -
Çekçe -
EMA (European Medicines Agency)
dimethyl fumarate polpharma
zaklady farmafarmaceutyczne polpharma s.aceutyczne polpharma s.a. - dimethyl fumarát - roztroušená skleróza, relaps-remitentní - imunosupresiva - dimethyl fumarate polpharma is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.
Avrupa Birliği -
Çekçe -
EMA (European Medicines Agency)
dimethyl fumarate neuraxpharm
laboratorios lesvi s.l. - dimethyl fumarát - roztroušená skleróza, relaps-remitentní - imunosupresiva - dimethyl fumarate neuraxpharma is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.
Avrupa Birliği -
Çekçe -
EMA (European Medicines Agency)
dimethyl fumarate teva
teva gmbh - dimethyl fumarát - multiple sclerosis, relapsing-remitting; multiple sclerosis - imunosupresiva - dimethyl fumarate teva is indicated for the treatment of adult and paediatric patients aged 13 years and older with relapsing remitting multiple sclerosis (rrms).